|
Volumn 24, Issue 6, 2003, Pages 608-610
|
Congenital Heart Disease with Hypereosinophilic Syndrome
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
PROSTAGLANDIN E1;
STEROID;
ARTICLE;
BLALOCK TAUSSIG ANASTOMOSIS;
CARDIOVASCULAR DISEASE;
CASE REPORT;
CESAREAN SECTION;
CLIMATE;
CLINICAL FEATURE;
CONGENITAL HEART DISEASE;
CYANOSIS;
DIAGNOSTIC IMAGING;
DISEASE ACTIVITY;
DISEASE ASSOCIATION;
DISEASE COURSE;
DISEASE DURATION;
DRUG MEGADOSE;
DRUG RESPONSE;
EMBOLISM;
ENDOCARDIAL DISEASE;
EOSINOPHIL;
EOSINOPHILIA;
FEMALE;
HEART ATRIUM SEPTUM DEFECT;
HEART CATHETERIZATION;
HEART MUSCLE FIBROSIS;
HEART RIGHT VENTRICLE;
HUMAN;
HYPEREOSINOPHILIC SYNDROME;
HYPOPLASIA;
INCIDENCE;
INTRAUTERINE GROWTH RETARDATION;
LABORATORY TEST;
LEUKOCYTE COUNT;
MORBIDITY;
MORTALITY;
NEWBORN;
ONSET AGE;
PATENT DUCTUS ARTERIOSUS;
PULMONARY VALVE STENOSIS;
RESTRICTIVE CARDIOMYOPATHY;
SURGICAL INFECTION;
SYSTEMIC DISEASE;
THORACOTOMY;
THROMBOGENESIS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT PLANNING;
TRICUSPID VALVE STENOSIS;
VALVULAR HEART DISEASE;
FEMALE;
HEART DEFECTS, CONGENITAL;
HUMANS;
HYPEREOSINOPHILIC SYNDROME;
INFANT, NEWBORN;
|
EID: 0344010703
PISSN: 01720643
EISSN: None
Source Type: Journal
DOI: 10.1007/s00246-002-0464-1 Document Type: Article |
Times cited : (4)
|
References (9)
|